More Related Content
Similar to Ppt chapter 52-1
Similar to Ppt chapter 52-1 (20)
More from stanbridge (20)
Ppt chapter 52-1
- 1. Drugs Affecting the Urinary Tract
and the Bladder
Chapter 52
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
- 2. Urinary Tract Infections (UTIs)
• Second most common infection in the U.S.
• More common in females
• Patients with indwelling catheters or intermittent
catherization are at risk
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
- 3. Signs and Symptoms of a UTI
• Urinary frequency
• Urgency
• Burning on urination (associated with cystitis)
• Chills, fever, flank pain, and tenderness (associated with
acute pyelonephritis)
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
- 4. Treatment for UTIs
• Antibiotics
• Specific agents to sterilize the urinary tract
• Drugs that:
– Block spasms of the urinary tract muscles
– Decrease urinary tract pain
– Protect the cells of the bladder from irritation
– Treat enlargement of the prostate gland in men
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
- 5. Sites of Action of Drugs Acting on the
Urinary Tract
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
- 6. Anti-Infectives Used to Treat UTI
• Cinoxacin (Cinobac): Interferes with DNA replication in
gram-negative bacteria
• Norfloxacin (Noroxin): Effective against even more gram-negative
strains than is cinoxacin
• Fosfomycin (Monurol): Has the convenience of only one
dose
• Nalidixic Acid (NegGram): Older drug, not effective
against as many strains of gram-negative bacteria
• Nitrofurantoin (Furadantin): Older drug with a very short
half-life
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
- 7. Anti-Infectives That Acidify the Urine
• Methenamine (Hiprex)
– Undergoes metabolism in the liver and is excreted in
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
urine
– Has established dosage guidelines for children and
comes in a suspension form
• Methylene Blue (Urolene Blue)
– Is widely distributed, metabolized in the tissues, and
excreted in urine, bile, and feces
- 8. Anti-Infectives
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
• Actions
– Act specifically within the urinary tract to destroy
bacteria
– They act either through direct antibiotic effect or
through acidification
• Indications
– Chronic UTI
– Adjunctive therapy in acute cystitis and
pyelonephritis
– Prophylaxis with urinary tract anatomical
abnormalities and residual urine disorders
- 9. Anti-Infectives (cont.)
• Pharmacokinetics
– Vary with each drug
• Contraindications
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
– Allergy
• Caution
– Renal dysfunction
– Pregnancy and lactation
- 10. Anti-Infectives (cont.)
• Adverse Effects
– Nausea, vomiting, anorexia, bladder irritation, and
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
dysuria
– Pruitus, urticaria, headache, dizziness, nervousness,
and confusion
• Drug-to-Drug Interactions
– Vary with each agent
- 11. Question
What type of drugs are used to treat UTIs?
A. Broad spectrum antibiotics
B. Those that protect the cells of the bladder from
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
irritation
C. Quinine-based medications
D. Beta blockers
- 12. Answer
B. Protect the cells of the bladder from irritation
Rationale: Drugs that: block spasms of the urinary tract
muscles; decrease urinary tract pain; protect the cells of
the bladder from irritation; treat enlargement of the
prostate gland in men
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
- 13. Urinary Tract Antispasmodics
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
• Actions
– Block the spasms of urinary tract muscles
– Blocking parasympathetic activity
– Relaxing the detrusor and other urinary tract muscles
• Indications
– Bladder spasm and dysuria
- 14. Urinary Tract Antispasmodics (cont.)
• Pharmacokinetics
– Rapidly absorbed, widely distributes
– Metabolized in the liver and excreted in the urine
• Contraindications
– Allergy
– Pyloric or duodenal obstruction
– Recent surgery
– Obstructive urinary tract problems
– Glaucoma, myasthenia gravis, or acute hemorrhage
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
- 15. Urinary Tract Antispasmodics (cont.)
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
• Caution
– Renal or hepatic dysfunction
– Pregnancy and lactation
• Adverse Effects
– Related to blocking of the parasympathetic system
• Drug-to-Drug Interactions
– Phenothiazines
– Haloperidol
- 16. Urinary Tract Analgesia
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
• Actions
– When phenazopyridine is excreted in urine, it exerts
a direct topical analgesic effect on the urinary
mucosa
• Indications
– Relieve symptoms related to urinary tract irritation
from infection, trauma, or surgery
- 17. Urinary Tract Analgesia (cont.)
• Pharmacokinetics
– Rapidly absorbed and has a very rapid onset of
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
action
– Widely distributed
– Metabolized in the liver and excreted in the urine
• Contraindications
– Allergy and renal dysfunction
• Caution
– Pregnancy and lactation
- 18. Urinary Tract Analgesia (cont.)
• Adverse Effects
– GI upset, headache, rash, reddish-orange coloring of
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
the urine
– Renal and hepatic toxicity
• Drug-to-Drug Interactions
– Antibacterial agents
- 19. Bladder Protectants
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
• Actions
– Heparin-like compound that has anticoagulant and
fibrinolytic effects
– Adheres to the bladder wall mucosal membranes and
acts as a buffer to control cell permeability,
preventing irritating solutes in the urine from
reaching the bladder wall cells
• Indications
– Interstitial cystitis
- 20. Bladder Protectants (cont.)
• Pharmacokinetics
– Very little of the drug is absorbed
– Metabolized in the liver and spleen, and excreted in
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
the urine
• Contraindications
– Condition that involve a risk of bleeding
– Heparin induced thrombocytopenia
- 21. Bladder Protectants (cont.)
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
• Caution
– Hepatic or splenic dysfunction
– Pregnancy or lactation
• Adverse Effects
– Bleeding that may progress to hemorrhage
– Headache, alopecia, GI disturbances
• Drug-to-Drug Interactions
– Anticoagulants, aspirin, or NSAIDs
- 22. Drugs for Treatment of Benign Prostatic
Hyperplasia
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
• Actions
– Varies with drug
• Indications
– Treats benign prostatic hypertrophy
• Pharmacokinetics
– Varies with drug
• Contraindications
– Allergy
- 23. Drugs for Treatment of Benign Prostatic
Hyperplasia
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
• Cautions
– Hepatic or renal dysfunction
• Adverse Effects
– Varies with drug
– Headache, fatigue, dizziness, postural dizziness,
lethargy, tachycardia, hypotension, GI upset
– Decreased libido, impotence, and sexual dysfunction
• Drug-to-Drug Interactions
– Theophylline
- 24. Question
Please answer the following question as true or false.
An adverse effect of a bladder protectant is alopecia.
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
- 25. Answer
True
Rationale: Adverse Effects: bleeding that may progress to
hemorrhage; headache, alopecia, GI disturbances
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
- 26. Use of Drugs Affecting the Urinary Tract
Throughout the Lifespan
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
- 29. Prototype Drugs for Treatment of Benign
Prostatic Hyperplasia
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
- 30. Nursing Considerations for Anti-Infectives
• Assessment: History and Physical Exam
• Nursing Diagnosis
• Implementation
• Evaluation
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
- 31. Nursing Considerations for Urinary Tract
Antispasmodics
• Assessment: History and Physical Exam
• Nursing Diagnosis
• Implementation
• Evaluation
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
- 32. Nursing Considerations for Urinary Tract
Analgesia
• Assessment: History and Physical Exam
• Nursing Diagnosis
• Implementation
• Evaluation
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
- 33. Nursing Considerations for Bladder
Protectants
• Assessment: History and Physical Exam
• Nursing Diagnosis
• Implementation
• Evaluation
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
- 34. Nursing Considerations for Drugs for
Treatment of Benign Prostatic Hyperplasia
• Assessment: History and Physical Exam
• Nursing Diagnosis
• Implementation
• Evaluation
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
- 35. Question
What is an appropriate nursing diagnoses for a patient
taking a urinary anti-infective?
A. Disturbed sensory perception (kinesthetic, tactile,
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
visual)
B. Incontinence
C. Chronic pain
D. Discolored urine
- 36. Answer
A. Disturbed sensory perception (kinesthetic, tactile,
visual)
Rationale: Nursing diagnoses related to drug therapy might
include: acute pain related to GI, CNS, or skin effects of
drug; disturbed sensory perception (kinesthetic, tactile,
visual) related to CNS effects; impaired urinary
elimination related to underlying problem necessitating
drug therapy; risk for injury related to possible CNS
effects; deficient knowledge regarding drug therapy
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins